TREPROSTINIL SODIUM

( DrugBank: Treprostinil / KEGG DRUG: Treprostinil )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1
86	肺動脈性肺高血圧症	19

告示番号	疾患名（ページ内リンク）	臨床試験数
88	慢性血栓塞栓性肺高血圧症	5

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002444-24-GB (EUCTR)	18/02/2020	18/12/2019	Clinical trial of a single dose of treprostinil injected as a depot under the skin to investigate th ...	An Exploratory Trial Assessing Vascular Digital Perfusion, Pharmacokinetics, Safety and Tolerability ...	Raynaud’s phenomenon secondary to systemic sclerosis MedDRA version: 20.0;Level: PT;Classification c ...	Product Name: CAM2043 Product Code: CAM2043 INN or Proposed INN: Treprostinil Sodium Other descriptive ...	Camurus AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	12	Phase 2	United Kingdom

First Previous1Next Last

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 10 of 19 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-004002-21-AT (EUCTR)	26/11/2021	06/09/2021	A non-randomized, single-center, open, two-period study with paired design to compare measured stead ...	A single center, open-label, two-period, non-randomized, paired-design study to compare steady-state ...	pulmonary arterial hypertension MedDRA version: 21.1;Level: PT;Classification code 10064911;Term: Pu ...	Product Name: 20 mg/ml Treprostinil INN or Proposed INN: treprostinil sodium Other descriptive name: T ...	AOP Orphan Pharmaceuticals GmbH	NULL	Not Recruiting			Female: yes Male: yes	16	Phase 2	Austria
2	EUCTR2018-003414-40-DE (EUCTR)	31/01/2019	06/11/2018	A Two Part Clinical Study to Evaluate the Effect of Different Doses and the Safety of Inhaled Trepro ...	A Two Part, Phase 2 Open-label, Multi-Centre, Dose Escalation Hemodynamic Study to Evaluate Dose-Res ...	Pulmonary Arterial Hypertension (WHO Group 1) MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: LIQ861 26.5 µg INN or Proposed INN: Treprostinil Sodium Other descriptive name: TREPROST ...	Liquidia Technologies, Inc.	NULL	Not Recruiting			Female: yes Male: yes	32	Phase 2	France;Germany
3	EUCTR2018-003414-40-FR (EUCTR)	21/01/2019	06/11/2018	A Two Part Clinical Study to Evaluate the Effect of Different Doses and the Safety of Inhaled Trepro ...	A Two Part, Phase 2 Open-label, Multi-Centre, Dose Escalation Hemodynamic Study to Evaluate Dose-Res ...	Pulmonary Arterial Hypertension (WHO Group 1) MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: LIQ861 25 µg INN or Proposed INN: Treprostinil Sodium Other descriptive name: TREPROSTIN ...	Liquidia Technologies, Inc.	NULL	Not Recruiting			Female: yes Male: yes	32	Phase 2	France;Germany
4	EUCTR2011-004631-31-DE (EUCTR)	13/03/2012	10/02/2012	16 week study is to assess the safety, tolerability and the effects on the body of a rapid dosing re ...	A 16 Week, Open Label, Multi-Centre, Study to Evaluate the Safety, Tolerability and Pharmacodynamic ...	Pulmonary Arterial Hypertension (PAH) MedDRA version: 14.1;Level: PT;Classification code 10064911;Te ...	Trade Name: Remodulin® (treprostinil) 1 mg/ml solution for infusion INN or Proposed INN: Treprostinil ...	United Therapeutics Corp.	NULL	Not Recruiting			Female: yes Male: yes	50		Germany
5	EUCTR2011-001312-59-GB (EUCTR)	24/06/2011	15/04/2011	A double-blinded, randomized, crossover clinical study to assess the efficacy of Qutenza (capsaicin ...	A double-blinded, randomized, crossover clinical study to assess the efficacy of Qutenza (capsaicin ...	Pulmonary arterial hypertension (PAH) is a rare life-threatening disease characterised by high blood ...	Trade Name: Qutenza Product Name: Qutenza INN or Proposed INN: Capsaicin	Imperial College London	NULL	Not Recruiting			Female: yes Male: yes	0		United Kingdom
6	NCT00643604 (ClinicalTrials.gov)	March 2008	20/3/2008	Rapid Switch From Flolan to Remodulin in the Outpatient Clinic	Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) in Patien ...	Hypertension, Pulmonary	Drug: treprostinil sodium	United Therapeutics	NULL	Terminated	18 Years	70 Years	All	7	Phase 4	United States
7	NCT00458042 (ClinicalTrials.gov)	March 2007	5/4/2007	Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Sat ...	Transitioning To Intravenous Remodulin® (Treprostinil Sodium) From Inhaled Iloprost (Ventavis®) in P ...	Hypertension, Pulmonary	Drug: treprostinil sodium	United Therapeutics	NULL	Terminated	18 Years	65 Years	Both	10	Phase 4	United States
8	EUCTR2004-003236-59-ES (EUCTR)	14/02/2007	05/05/2010		Investigación clínica doble ciego controlada con placebo sobre la efficacia y la tolerabilidad de Tr ...	Hipertensión Arterial Pulmonar Grave de clase III y IV de la NYHANYHA Class III and IV patients with ...	Product Name: Treprostinil SodiumSolution for Inhalation Product Code: N/A INN or Proposed INN: N/A Oth ...	United Therapeutics Corporation	NULL	Not Recruiting			Female: yes Male: yes	220		Germany;United Kingdom;Ireland;Spain;Italy
9	NCT00439946 (ClinicalTrials.gov)	February 2007	22/2/2007	Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five ...	Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) Using the ...	Pulmonary Arterial Hypertension	Drug: treprostinil;Device: Crono Five ambulatory pump	United Therapeutics	NULL	Terminated	18 Years	65 Years	All	8	Phase 4	United States
10	NCT00373360 (ClinicalTrials.gov)	September 2006	7/9/2006	Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol ...	Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) in Patien ...	Pulmonary Hypertension	Drug: treprostinil sodium	United Therapeutics	NULL	Completed	18 Years	70 Years	All	10	Phase 4	United States

First Previous1 2Next Last

88. 慢性血栓塞栓性肺高血圧症

臨床試験数 : 157 / 薬物数 : 107 - (DrugBank : 22) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 54

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-006441-10-DE (EUCTR)	27/05/2010	28/01/2010	Double Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously ...	Double Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously ...	Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary Hypertension	Trade Name: Remodulin 1mg/ml 20ml Other descriptive name: TREPROSTINIL SODIUM Trade Name: Remodulin 2. ...	MRN-Medical Research Network GmbH	NULL	Not Recruiting			Female: yes Male: yes	100		Czech Republic;Germany;Austria
2	EUCTR2008-006441-10-CZ (EUCTR)	15/10/2009	24/07/2009	Study to evaluate the efficacy and safety of Treprostinil which will becontinuously administered und ...	A double blind controlled clinical study to investigate the efficacy and tolerability of subcutaneou ...	Patients with Severe inoperable Chronic Thromboembolic Pulmonary Hypertension;Therapeutic area: Dise ...	Product Name: Treprostinil Sodium INN or Proposed INN: Treprostinil Other descriptive name: TREPROSTIN ...	SCIPHARM SáRL	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	Czech Republic;Slovakia;Poland;Austria;Germany
3	EUCTR2008-006441-10-SK (EUCTR)	31/08/2009	09/09/2009	Double Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously ...	Double Blind Controlled Clinical Investigation into the Efficacy and Tolerability of subcutaneously ...	Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary Hypertension	Trade Name: Remodulin (R) Trade Name: Remodulin (R)	MRN-Medical Research Network GmbH	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	Czech Republic;Slovakia;Austria;Germany
4	EUCTR2008-006441-10-AT (EUCTR)	03/06/2009	09/12/2008	Study to evaluate the efficacy and safety of Treprostinil which will becontinuously administered und ...	A double blind controlled clinical study to investigate the efficacy and tolerability of subcutaneou ...	Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary Hypertension;Therapeutic area: Di ...	Product Name: Treprostinil Sodium INN or Proposed INN: Treprostinil Other descriptive name: TREPROSTIN ...	SCIPHARM SáRL	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 3	Czech Republic;Slovakia;Poland;Austria;Germany
5	NCT01416636 (ClinicalTrials.gov)	March 2009	12/8/2011	Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodiumin Patients With Severe ...	A Double Blind Controlled Clinical Study to Investigate the Efficacy and Tolerability of Subcutaneou ...	Non-operable Chronic Thromboembolic Pulmonary Hypertension	Drug: Treprostinil sodium	SciPharm SàRL	NULL	Active, not recruiting	18 Years	100 Years	All	105	Phase 3	Austria;Czechia;Germany;Poland;Czech Republic

First Previous1Next Last